Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Qin-Hua Zhao, Fu-Hua Peng, Zai-Xin Yu, Gang-Cheng Zhang, Qiu-Shang Ji, Yong Wang, Jin-Ming Liu, Yong Huo, Xiao-Feng Zeng, Jian-Hui Li, Lu Zi & Zhi-Cheng Jing. (2020) Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension. Expert Review of Cardiovascular Therapy 18:9, pages 643-649.
Read now
Read now
Articles from other publishers (36)
Junichi Omura, Kazuki Kitahara, Masashi Takano, Koki Idehara & Seok‐Won Kim. (2023) Real‐world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database. Pulmonary Circulation 13:3.
Crossref
Crossref
Marco Caccamo, Frank E. Harrell & Anna R. Hemnes. (2023) Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension. Pulmonary Circulation 13:3.
Crossref
Crossref
Angkawipa Trongtorsak, Sittinun Thangjui, Pabitra Adhikari, Biraj Shrestha, Jakrin Kewcharoen, Leenhapong Navaravong, Somsupha Kanjanauthai, Steve Attanasio & Hammad A. Saudye. (2023) Gender Disparities after Transcatheter Aortic Valve Replacement with Newer Generation Transcatheter Heart Valves: A Systematic Review and Meta-Analysis. Medical Sciences 11:2, pages 33.
Crossref
Crossref
Betty J. Allen, Hailey Frye, Rasika Ramanathan, Laura R. Caggiano, Diana M. Tabima, Naomi C. Chesler & Jennifer L. Philip. (2023) Biomechanical and Mechanobiological Drivers of the Transition From PostCapillary Pulmonary Hypertension to Combined Pre−/PostCapillary Pulmonary Hypertension. Journal of the American Heart Association 12:3.
Crossref
Crossref
Iona Cuthbertson, Nicholas W. Morrell & Paola Caruso. (2023)
BMPR2
Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension
. Circulation Research 132:1, pages 109-126.
Crossref
Crossref
Tadej Debevec, Benjamin J. Narang, Giorgio Manferdelli & Grégoire P. Millet. (2022) Premature birth: a neglected consideration for altitude adaptation. Journal of Applied Physiology 133:4, pages 975-978.
Crossref
Crossref
Joseph W. Duke, Adam J. Lewandowski, Steven H. Abman & Andrew T. Lovering. (2022) Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm. The Journal of Physiology 600:3, pages 463-482.
Crossref
Crossref
Richa Tyagi, Surya Kant, Akshyaya Pradhan, Anupam Wakhlu, Darshan Kumar Bajaj & Jyoti Bajpai. (2021) Estimates of Prevalence of Pulmonary Hypertension according to Different International Definitions. Canadian Respiratory Journal 2021, pages 1-8.
Crossref
Crossref
Yasmine Amgoud, Amira Senbel, Amel Bouhadoun, Heba Abdelazeem, Gulsev Ozen, Ines Savané, Hasanga D. Manikpurage, Salma Mani, Alexy Tran-Dinh, Yves Castier, Alice Guyard, Dan Longrois, Adam M. Silverstein & Xavier Norel. (2021) In search of pulmonary hypertension treatments: Effect of 17β-estradiol on PGI2 pathway in human pulmonary artery. Prostaglandins, Leukotrienes and Essential Fatty Acids 172, pages 102321.
Crossref
Crossref
An Huang, Sharath Kandhi & Dong Sun. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
107
127
.
Ameen M. Mohammad, Mohammed M. Dawad, Muna A. Kashmoola & Nasir Al-Allawi. (2020) Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq. PLOS ONE 15:12, pages e0243648.
Crossref
Crossref
Mengtao Li, Zhi-Cheng Jing, Yang Li, Yong Huo, Zaixin Yu, Gangcheng Zhang, Ping Zhu, Jinming Liu, Qiushang Ji, Bingxiang Wu, Jinhua Zhong, Pingping Wang, Wenjing Zhu & Xiaofeng Zeng. (2020) Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis. BMC Cardiovascular Disorders 20:1.
Crossref
Crossref
Monika Spaczyńska, Susana F. Rocha & Eduardo Oliver. (2020) Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies. ACS Pharmacology & Translational Science 3:4, pages 598-612.
Crossref
Crossref
Grazyna KwapiszewskaAnne Katrine Z. JohansenJose Gomez-ArroyoNorbert F. Voelkel. (2019) Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases. Circulation Research 125:3, pages 356-366.
Crossref
Crossref
Vincent Avecilla. (2019) Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia. International Journal of Vascular Medicine 2019, pages 1-8.
Crossref
Crossref
Carolyn Doyle‐Cox, Gail Nicholson, Traci Stewart & Wendy Gin‐Sing. (2019) Current organization of specialist pulmonary hypertension clinics: results of an international survey. Pulmonary Circulation 9:2, pages 1-10.
Crossref
Crossref
Nina Denver, Shazia Khan, Ioannis Stasinopoulos, Colin Church, Natalie ZM. Homer, Margaret R. MacLean & Ruth Andrew. (2019) Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry. Analytica Chimica Acta 1054, pages 84-94.
Crossref
Crossref
Veronica Franco, John J. Ryan & Vallerie V. McLaughlin. (2019) Pulmonary Hypertension in Women. Heart Failure Clinics 15:1, pages 137-145.
Crossref
Crossref
Veronique Vorselaars, Anna Hosman, Cornelis Westermann, Repke Snijder, Johannes Mager, Marie-Jose Goumans & Marco Post. (2018) Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia. International Journal of Molecular Sciences 19:10, pages 3203.
Crossref
Crossref
Stephan P. L. Altmayer, Q. Joyce Han, Karima Addetia, Amit R. Patel, Paul R. Forfia & Yuchi Han. (2018) Using all-cause mortality to define severe RV dilation with RV/LV volume ratio. Scientific Reports 8:1.
Crossref
Crossref
Jesse W. Gerringer, Julie C. Wagner, Daniela Vélez-Rendón & Daniela Valdez-Jasso. (2018) Lumped-parameter models of the pulmonary vasculature during the progression of pulmonary arterial hypertension. Physiological Reports 6:3, pages e13586.
Crossref
Crossref
Jeffrey B Geske, Kevin C Ong, Konstantinos C Siontis, Virginia B Hebl, Michael J Ackerman, David O Hodge, Virginia M Miller, Rick A Nishimura, Jae K Oh, Hartzell V Schaff, Bernard J Gersh & Steve R Ommen. (2017) Women with hypertrophic cardiomyopathy have worse survival. European Heart Journal 38:46, pages 3434-3440.
Crossref
Crossref
Maria Beatrice Musumeci, Vittoria Mastromarino, Matteo Casenghi, Giacomo Tini, Pietro Francia, Antonello Maruotti, Antonella Romaniello, Damiano Magrì, Rosa Lillo, Carmen Adduci, Massimo Volpe & Camillo Autore. (2017) Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy. International Journal of Cardiology 248, pages 326-332.
Crossref
Crossref
Milena Issac, Jasper Dingemanse & Patricia N. Sidharta. (2017) Pharmacokinetics of Macitentan in Patients With Pulmonary Arterial Hypertension and Comparison With Healthy Subjects. The Journal of Clinical Pharmacology 57:8, pages 997-1004.
Crossref
Crossref
Kevin C. Ong, Jeffrey B. Geske, Virginia B. Hebl, Rick A. Nishimura, Hartzell V. Schaff, Michael J. Ackerman, Kyle W. Klarich, Konstantinos C. Siontis, Thais Coutinho, Joseph A. Dearani, Steve R. Ommen & Bernard J. Gersh. (2016) Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. European Heart Journal – Cardiovascular Imaging 17:6, pages 604-610.
Crossref
Crossref
Jennifer Rusiecki, Youlan Rao, Jody Cleveland, Zachary Rhinehart, Hunter C. Champion & Michael A. Mathier. (2015) Sex and Menopause Differences in Response to Tadalafil: 6‐Minute Walk Distance and Time to Clinical Worsening. Pulmonary Circulation 5:4, pages 701-706.
Crossref
Crossref
B.A. Naglaa, R.I.M. El-Korashy & Y.M.A. Soliman. (2015) Searching for the least invasive parameters used as predictors of survival in idiopathic pulmonary arterial hypertension. Egyptian Journal of Chest Diseases and Tuberculosis 64:3, pages 739-744.
Crossref
Crossref
J. B. Geske, T. Konecny, S. R. Ommen, R. A. Nishimura, P. Sorajja, H. V. Schaff, M. J. Ackerman & B. J. Gersh. (2013) Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy. European Heart Journal 35:30, pages 2032-2039.
Crossref
Crossref
Tim Lahm, Rubin M. Tuder & Irina Petrache. (2014) Progress in solving the sex hormone paradox in pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 307:1, pages L7-L26.
Crossref
Crossref
Jennifer Corbelli & Eleanor Bimla Schwarz. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
41
53
.
Jennifer Corbelli & Eleanor Bimla Schwarz. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
41
53
.
Yaser Jenab, Neda Ghaffari-Marandi, Azam Safir, Gita Ejmalian, Arezou Zoroufian, Arash Jalali & Mohammad Sahebjam. (2013) Sex‐Related Changes in Tissue Doppler Imaging Parameters Among Patients With Acute Pulmonary Thromboembolism. Journal of Ultrasound in Medicine 32:11, pages 1997-2005.
Crossref
Crossref
R. Gunnarsson, A. K. Andreassen, O. Molberg, A. S. Lexberg, K. Time, A. S. S. Dhainaut, L.-T. Bertelsen, O. Palm, K. Irgens, A. Becker-Merok, J. L. Nordeide, V. Johnsen, S. Pedersen, A. Proven, L. S. N. Garabet, T. Garen, T. M. Aalokken, I.-M. Gilboe & J. T. Gran. (2013) Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology 52:7, pages 1208-1213.
Crossref
Crossref
Tim Lahm, Marjorie Albrecht, Amanda J. Fisher, Mona Selej, Neel G. Patel, Jordan A. Brown, Matthew J. Justice, M. Beth Brown, Mary Van Demark, Kevin M. Trulock, Dino Dieudonne, Jagadeshwar G. Reddy, Robert G. Presson & Irina Petrache. (2012) 17β-Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor–mediated Effects. American Journal of Respiratory and Critical Care Medicine 185:9, pages 965-980.
Crossref
Crossref
M. Schopper, P.I. Bäumler, J. Fleckenstein & D. Irnich. (2012) Gender-Aspekte in der AnästhesieGender aspects in anesthesia. Der Anaesthesist 61:4, pages 288-298.
Crossref
Crossref
Ehsan Ullah Khan. (2011) Commentary on Symptom Experience of Pulmonary Arterial Hypertension (PAH) Patients. Clinical Nursing Research 20:2, pages 135-143.
Crossref
Crossref